Clinical Trials
42 trialsA Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc.
ArchAid-002
Beijing GoBroad Hospital
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Tongji Hospital
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Tongji Hospital
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Reunion Neuroscience Inc
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Hadassah Medical Organization
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Gilead Sciences
AIM
University of Iowa
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
EREVA
Centre Hospitalier Régional d'Orléans
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Quality Improvement and Practice Based Research in Neurology Using the EMR
Endeavor Health
CAR-AID
RenJi Hospital
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Telex
Burke Medical Research Institute
DANCEREX-DTx
Fondazione Don Carlo Gnocchi Onlus
Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
Xuanwu Hospital, Beijing
CARTinNS
Tongji Hospital
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer
Click Therapeutics, Inc.
T-ScEmo4ALL
University Medical Center Groningen
EMBOLD
Atara Biotherapeutics
LSFG-SKIN, Laser Speckle Flowgraphy
University of Iowa
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms
Click Therapeutics, Inc.
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Alliance Foundation Trials, LLC.
COVIVAC-ID
Assistance Publique - Hôpitaux de Paris
OMNI-Can
OMNI Medical Services, LLC
NEUROSEX
Assistance Publique - Hôpitaux de Paris
Neurology Inpatient Clinical Education Trial
Dartmouth-Hitchcock Medical Center
PReSuTINeB
Buckinghamshire Healthcare NHS Trust
Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients
Isfahan University of Medical Sciences
Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging
Loma Linda University
Central Pain Study for ABX-1431
Abide Therapeutics
ASCEND in SPMS
Biogen
CHAMPIONS10
Beth Israel Deaconess Medical Center
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
University of Southern California
Timing of Acute Palliative Care Consultation in Critically Ill Patients
Wayne State University
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
University of Arizona
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Office of Rare Diseases (ORD)